LIST: MARKET LIKES TECHNOLOGY, BUT PRIVATE PLACEMENT NEWS DAMPENS THE ENTHUSIASM.

FDA Approval Sends Up Shares of Second Sight

By Mark Madler

Monday, March 29, 2021

Shares of Second Sight Medical Products Inc. shot up early this month following the approval by the U.S. Food & Drug Administration for the Sylmar company’s Argus IIs retinal prosthesis system.
...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 26 biweekly issues
  • Subscriber-only digital content for prime stories
  • Book of Lists — the most comprehensive business resource in the Valley region
Yours for only $49